Ariel Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,750
| Closed | -$805K | – | 119 |
|
|
2023
Q1 | $805K | Hold |
8,750
| – | – | 0.01% | 106 |
|
|
2022
Q4 | $794K | Hold |
8,750
| – | – | 0.01% | 108 |
|
|
2022
Q3 | $665K | Sell |
8,750
-1,239
| -12% | -$103K | 0.01% | 105 |
|
|
2022
Q2 | $844K | Sell |
9,989
-235
| -2% | -$20.6K | 0.01% | 102 |
|
|
2022
Q1 | $897K | Sell |
10,224
-407
| -4% | -$35.2K | 0.01% | 102 |
|
|
2021
Q4 | $930K | Sell |
10,631
-7,905
| -43% | -$656K | 0.01% | 102 |
|
|
2021
Q3 | $1.52M | Sell |
18,536
-2,046
| -10% | -$184K | 0.01% | 106 |
|
|
2021
Q2 | $1.88M | Hold |
20,582
| – | – | 0.02% | 101 |
|
|
2021
Q1 | $1.76M | Buy |
20,582
+155
| +0.8% | +$13.9K | 0.02% | 106 |
|
|
2020
Q4 | $1.93M | Buy |
20,427
+13
| +0.1% | +$1.14K | 0.02% | 120 |
|
|
2020
Q3 | $1.77M | Buy |
20,414
+70
| +0.3% | +$6.06K | 0.03% | 126 |
|
|
2020
Q2 | $1.78M | Sell |
20,344
-20,760
| -51% | -$1.79M | 0.03% | 132 |
|
|
2020
Q1 | $3.39M | Buy |
41,104
+14,966
| +57% | +$1.34M | 0.06% | 117 |
|
|
2019
Q4 | $2.48M | Sell |
26,138
-2,550
| -9% | -$229K | 0.03% | 130 |
|
|
2019
Q3 | $2.49M | Sell |
28,688
-281
| -1% | -$25.2K | 0.03% | 131 |
|
|
2019
Q2 | $2.65M | Sell |
28,969
-3,256
| -10% | -$276K | 0.03% | 138 |
|
|
2019
Q1 | $2.78M | Buy |
32,225
+1,398
| +5% | +$112K | 0.03% | 139 |
|
|
2018
Q4 | $2.37M | Sell |
30,827
-47,716
| -61% | -$3.71M | 0.03% | 141 |
|
|
2018
Q3 | $6.06M | Buy |
78,543
+1,510
| +2% | +$112K | 0.07% | 131 |
|
|
2018
Q2 | $5.21M | Sell |
77,033
-423
| -0.5% | -$29.2K | 0.06% | 137 |
|
|
2018
Q1 | $5.61M | Buy |
77,456
+1,537
| +2% | +$117K | 0.06% | 136 |
|
|
2017
Q4 | $5.71M | Buy |
75,919
+11,529
| +18% | +$870K | 0.06% | 139 |
|
|
2017
Q3 | $4.95M | Buy |
64,390
+8,964
| +16% | +$677K | 0.06% | 146 |
|
|
2017
Q2 | $4.15M | Buy |
55,426
+1,036
| +2% | +$73.4K | 0.05% | 154 |
|
|
2017
Q1 | $3.62M | Buy |
54,390
+37,201
| +216% | +$2.48M | 0.04% | 161 |
|
|
2016
Q4 | $1.12M | Buy |
17,189
+1,661
| +11% | +$108K | 0.01% | 182 |
|
|
2016
Q3 | $1.1M | Sell |
15,528
-1,009
| -6% | -$73.5K | 0.01% | 181 |
|
|
2016
Q2 | $1.22M | Buy |
16,537
+1,699
| +11% | +$117K | 0.02% | 181 |
|
|
2016
Q1 | $963K | Buy |
14,838
+2,264
| +18% | +$154K | 0.01% | 187 |
|
|
2015
Q4 | $969K | Buy |
+12,574
| New | +$999K | 0.01% | 186 |
|
Other funds holding NVS
Ariel Investments's NVS Position: Q2 2023 in Review
Ariel Investments sold out of Novartis (NVS) in Q2 2023, closing a stake of 8,750 shares — an estimated $805K sold.
Ariel Investments first reported a position in NVS in Q4 2015 and held it in 30 quarters. The position peaked at $6.06M in Q3 2018. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Ariel Investments reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
- Ariel Investments sold 8,750 Novartis shares in Q2 2023, an estimated $805K.
- Ariel Investments first reported a position in Novartis in Q4 2015 and held it in 30 quarters.
- Ariel Investments's Novartis position peaked at $6.06M in Q3 2018.
- 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Ariel Investments's 13F filing for Q2 2023, filed 14 Aug 2023.